Herbs & Botanicals

INS Farms, the largest grower/processor and supplier of black elderberry in North America, has entered into the natural health ingredient space with its Elder Pure line of elderberry raw materials. 

Like all of Gaia Herbs’ products, the new hemp extracts are fully traceable through the company’s Meet Your Herbs program.

As mushroom-product sales skyrocket globally, here is a look at some of the biggest players.

Carbon-14 testing to verify biobased ingredients is more important in light of the growing potential for fraud in the food and flavor industries.

A recent randomized, double-blind, placebo-controlled clinical study conducted by the Center for Applied Health Sciences found that a hemp oil extract manufactured by CV Sciences supported sleep, reduced appetite, and improved the overall quality of life. 

The American Herbal Products Association has submitted comments to the U.S. Trade Representative, urging the agency to remove herbal product ingredients from the latest list of Chinese goods that would be subject to a 25% ad valorem duty. 

A recent clinical trial published in The Journal of Nutrition adds to the existing body of evidence that curcumin can be used safely as an adjuvant therapy with cancer drugs. 

U.S. contract laboratory Alkemist Labs is partnering with Canadian contract research organization Nutrasource to launch the new third-party certification program.

A study recently published in BCM Complementary and Alternative Medicine shows that a standardized extract of Phyllanthus emblica fruit, otherwise known as amla, supports endothelial function, oxidative stress, immune response, and lipid profile.

A look at a few new turmeric/curcumin products that launched in the past year.

Global firm Diana Food (France) has opened a Canadian R&D laboratory in Quebec City, which will focus on creating new products and processes for consumer health.

Stress management is a big part of functional beverage trends, and CBD gets a new player with a lot of experience in seed-to-shelf vertical integration. 

Researchers from Western Sydney University will explore HydroCurc’s potential to reduce inflammation in the brain.

The American Urological Association’s new guidelines emphasize the need for non-antibiotic alternatives for reducing recurrent urinary tract infections-and highlight cranberry as an effective means of prevention.

In a statement last week on CBD regulation, FDA emphasized the need for clinical research, with no new details on a possible regulatory pathway for CBD food and dietary supplements. 

Quick tips on scrutinizing the CBD supply chain from a hemp extract and CBD company.

Consumer needs and new ingredient research are influencing how brands successfully develop and market antioxidant supplements.

Subjects taking standardized curcumin formulation BCM-95 showed similar improvements as subjects taking NSAIDs, with significantly few adverse events.

BacoMind from Natural Remedies is now self-affirmed GRAS

In the latest controversy over FDA and vinpocetine, the agency has issued a warning to women of childbearing age from taking vinpocetine products.

Atrium Innovations is now using VESIsorb, a patented delivery system for improving ingredient absorption, for hemp cannabidiol (CBD) products in its healthcare-professional brands Pure Encapsulations, Douglas Laboratories, and Genestra Brands.

Sabinsa’s patented color-free Curcumin C3 Reduct has been found to meet the criteria to be considered Generally Recognized as Safe (GRAS) following a comprehensive review of safety and toxicology data. 

MCTs are increasingly popular among consumers and product makers, in part due to their ease of use as well as their health benefits.

At FDA’s highly anticipated public hearing on hemp cannabidiol (CBD) today, May 31, the message from dietary supplement industry representatives was clear: The supplement industry needs a regulatory pathway for CBD-and needs it now.

CBD may be the hottest ingredient on the block, but don’t overlook hemp’s other promising cannabinoids, including cannabigerol (CBG), cannabichromene (CBC), and cannabinol (CBN). This article discusses exciting avenues of product development for manufacturers looking to work with a wider range of cannabinoids, as well as the challenges that remain.